Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia

Summary

Phase II trial to study the effectiveness of flavopiridol in treating patients who have chronic lymphocytic leukemia that has not responded to treatment with fludarabine. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die

Timeline

Start

1999-06

Primary completion

2006-06

Completion

—

Drugs

Indications